Abbott Receives FDA Approval for the FreeStyle Libre Pro System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients

News The continuous glucose monitoring system, which requires no finger-sticks for calibration, is designed to provide a clear, visual snapshot of a patient's glucose levels, trends and patterns for up to 14 days. Contributed Author:  Abbott Topics:  Diabetes